This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease or Coronary Angioplasty
and you are
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study investigates potential protective effect of atorvastatin pre-treatment in patient with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) on chronic statin therapy. Patients are randomized into two groups: atorvastatin pre-treatment group (80mg atorvastatin seven days before PCI) and control group (PCI without atorvastatin pretreatment, chronic statin treatment). Endpoint is myocardial infarction measured by troponin I and creatine kinase myocardial band.

Provided treatments

  • Drug: atorvastatin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01058057. The sponsor of the trial is University Hospital, Motol and it is looking for 200 volunteers for the current phase.
Official trial title:
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study 2